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Control of mitotic events by the Cdc42 GTPase, the Clb2 cyclin
and a member of the PAK kinase family
Hendri Tjandra, Jennifer Compton and Douglas Kellogg
Background: Cyclins and cyclin-dependent kinases induce and coordinate the
events of the cell cycle, although the mechanisms by which they do so remain
largely unknown. In budding yeast, a pathway used by the Clb2 cyclin to control
bud growth during mitosis provides a good model system in which to understand
how cyclin-dependent kinases control cell-cycle events. In this pathway, Clb2
initiates a series of events that lead to the mitosis-specific activation of the Gin4
protein kinase. A protein called Nap1 is required in vivo for the activation of
Gin4, and is able to bind to both Gin4 and Clb2. We have used a simple genetic
screen to identify additional proteins that function in this pathway.
Results: We have found that the Cdc42 GTPase and a member of the PAK
kinase family called Cla4 both function in the pathway used by Clb2 to control
bud growth during mitosis. Cdc42 and Cla4 interact genetically with Gin4 and
Nap1, and both are required in vivo for the mitosis-specific activation of the
Gin4 kinase. Furthermore, Cla4 undergoes a dramatic hyperphosphorylation in
response to the combined activity of Nap1, the Clb2—Cdc28 kinase complex,
and the GTP-bound form of Cdc42. Evidence is presented which suggests that
the hyperphosphorylated form of Cla4 is responsible for relaying the signal to
activate Gin4.
Conclusions: Previous studies have suggested that cyclin-dependent kinases
control the cell cycle by directly phosphorylating proteins involved in specific
events, such as nuclear lamins, microtubule-associated proteins and histones.
In contrast, our results demonstrate that the Clb2—Cdc28 cyclin-dependent
kinase complex controls specific cell-cycle events through a pathway that
involves a GTPase and at least two different kinases. This suggests that cyclin-
dependent kinases may control many cell-cycle events through GTPase-linked
signaling pathways that resemble the intricate signaling pathways known to
control many other cellular events.
Background
The events of cell division are controlled by a family of
proteins called cyclin-dependent kinases, which are acti-
vated at specific stages of the cell cycle when they bind
to members of the cyclin family of proteins [1,2].
Although considerable progress has been made towards
understanding the regulation of cyclin-dependent
kinases, we still know little about the molecular pathways
used by these kinases to induce the actual events of cell
division. Simple organisms use a single cyclin-dependent
kinase to induce the events of both interphase and
mitosis, demonstrating that the same cyclin-dependent
kinase can induce different events when activated at dif-
ferent times during the cell cycle. We do not yet under-
stand the molecular mechanisms that make such
specificity possible.
The fact that cyclin-dependent kinases are bound to dif-
ferent cyclins at each stage of the cell cycle suggests that
the cyclins function to determine the cell-cycle events
induced by specific cyclin-dependent kinase complexes.
In previous work we reasoned that in order for cyclins to
confer this kind of specificity they must bind to specific
proteins involved in the control of cell-cycle events, and
we used affinity chromatography to search for such pro-
teins [3]. This led to the identification of a highly con-
served protein called Nap1 which binds specifically to
mitotic cyclins in organisms as divergent as vertebrates
and yeast. In budding yeast, Nap1 binds to the mitotic
cyclin Clb2 and is required for the ability of Clb2 to
induce specific mitotic events. One of these events is a
switch in the pattern of bud growth that occurs as cells
enter mitosis [4]. A newly formed bud initially grows only
at its tip; however, during mitosis the Clb2–Cdc28 kinase
complex causes bud growth to occur over the entire bud
surface, leading to the formation of a round bud [5,6].
Without Nap1, the Clb2–Cdc28 kinase complex is unable
to induce this switch in the pattern of bud growth and the
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new bud therefore continues to grow at its tip during
mitosis, giving rise to highly elongated buds [4].
The pathway used by Clb2 to control bud growth during
mitosis is not essential for viability, and cells with defects
in this pathway can easily be identified in genetic screens
because they give rise to colonies with a peculiar morphol-
ogy [3,4,7]. This pathway therefore represents an ideal
genetic model system in which to understand the mecha-
nisms used by cyclin-dependent kinases to control spe-
cific cell-cycle events. By screening for mutations that
disrupt the control of bud growth during mitosis, we iden-
tified a protein kinase called Gin4 [7]. The phenotype
caused by deletion of the GIN4 gene is nearly identical to
the phenotype caused by deletion of the NAP1 gene, and
Gin4 binds tightly to Nap1. Furthermore, the kinase activ-
ity of Gin4 is specifically activated during mitosis in a
Nap1-dependent manner [7].
To learn more about the Clb2-dependent pathway that
controls bud growth during mitosis, we have characterized
a mutation that causes an elongated bud phenotype that
closely resembles the phenotype caused by loss of func-
tion of Gin4 or Nap1 in cells that are dependent upon
Clb2 for survival. These studies have demonstrated that
the Cdc42 GTPase and a member of the PAK kinase
family called Cla4 have important roles in the control of
mitotic events by the Clb2 cyclin.
Results
Cla4, a member of the PAK kinase family, functions in a
Clb2-dependent mitotic control pathway
In previous work we used a simple genetic screen to iden-
tify mutations that cause the formation of elongated buds
due to a disruption of the control of polar bud growth
during mitosis. This led to the identification of the Gin4
protein kinase, which has an important role in the control
of mitotic events by Clb2 [7]. In the same genetic screen
that identified Gin4, we isolated a mutation that causes an
elongated bud phenotype that closely resembles the phe-
notype caused by deletion of the GIN4 gene or of the
NAP1 gene (Figure 1). We cloned the gene identified by
this mutation and found that it encodes a previously iden-
tified member of the PAK kinase family called Cla4 [8].
Members of the PAK kinase family were first identified as
proteins that bind specifically to the GTP-bound form of
the Cdc42 GTPase, and members of the PAK kinase
family have been implicated in such diverse events as
actin cytoskeletal rearrangements, AIDS progression, and
signaling by the ras oncogene [9–13].
We found that deletion of the CLA4 gene causes an elon-
gated bud phenotype that is identical to the phenotype of
the mutation isolated in our screen. The elongated bud
phenotype caused by loss of Cla4 function strongly sug-
gested that Cla4 functions in the pathway used by Clb2,
Nap1 and Gin4 to control bud growth during mitosis. To
further test whether Cla4 functions in this pathway, we
looked for genetic and functional interactions between
Cla4 and the proteins known to function in the pathway.
We first tested for genetic interactions between CLA4,
GIN4 and NAP1. To do this, we constructed strains that
carry a CLA4 gene deletion in combination with either a
GIN4 or NAP1 gene deletion. In each case, we found that
cells carrying the double deletion were barely viable when
grown at 37°C, whereas cells carrying the single deletions
formed colonies at a normal or nearly normal rates
(Figure 2a). These results demonstrate that Cla4, Gin4
and Nap1 are involved in related functions within the cell.
We next determined whether Cla4 interacts genetically
with the mitotic cyclins. There are four mitotic cyclins in
budding yeast, called Clb1, Clb2, Clb3 and Clb4. These
cyclins are highly redundant, but cells can be made depen-
dent upon the Clb2 cyclin for viability by deleting the
genes for Clb1, Clb3 and Clb4 [14,15]. This is referred to as
a Clb2-dependent genetic background, and allows one to
study pathways controlled by Clb2 without the complica-
tion of redundant pathways controlled by other mitotic
cyclins. We had found previously that deletion of the genes
for Gin4 or Nap1 in a Clb2-dependent background results
in a much more severe phenotype than in a wild-type back-
ground, suggesting that Gin4 and Nap1 mediate Clb2-
dependent functions [3,7]. We tested whether the same is
true for Cla4 by examining the phenotype of a CLA4 dele-
tion in a wild-type and in a Clb2-dependent background.
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Figure 1
The phenotype of the ecm30 mutation identified in a screen for
mutations that cause an elongated cell morphology [7]. The mutant
strain shown here is in the Clb2-dependent strain background used for
the original genetic screen [7].
As with GIN4 and NAP1, we found that the elongated bud
phenotype of a CLA4 deletion was significantly enhanced
in the Clb2-dependent background (Figure 2b). CLA4 is
unique, however, in that deletion of the CLA4 gene pro-
duced a more severe phenotype in a wild-type background
than does deletion of the genes for either GIN4 or NAP1.
This might suggest that Cla4 also has a role in the pathways
used by the other mitotic cyclins to control bud growth.
Previous work has demonstrated genetic and physical inter-
actions between CLA4 and CDC42 [8,16]. We therefore
searched for genetic interactions between CDC42 and genes
encoding proteins that function in the Clb2-dependent
mitotic control pathway. We found that deletion of the NAP1
gene completely suppressed the temperature sensitivity of
the cdc42-1 allele, whereas deletion of the GIN4 gene did not
(Figure 2c). These results suggest that Nap1 and Cdc42 are
likely to function together within the cell, and they suggest
that Nap1 may be a negative regulator of Cdc42.
Cla4 is required for the mitosis-specific activation of the
Gin4 kinase
We next tested for functional interactions between Cla4
and Gin4. The Gin4 protein becomes hyperphosphorylated
during mitosis, which leads to activation of Gin4 kinase
activity [7]. Thus, the mitosis-specific activation of Gin4
can be conveniently detected by assaying for a hyperphos-
phorylation-induced shift in the electrophoretic mobility of
Gin4 [7]. By assaying the mitosis-specific hyperphosphory-
lation of Gin4 in synchronized cultures of ∆cla4 cells, we
found that Gin4 hyperphosphorylation was completely
dependent upon Cla4 in vivo (Figure 3a). Control experi-
ments showed that the Clb2 protein appeared at the same
time in wild-type and ∆cla4 cells, demonstrating that the
defect in Gin4 activation is not due to failure of ∆cla4 cells
to enter mitosis (Figure 3b). Note that Clb2 protein levels
remain high in the ∆cla4 cells, consistent with a prolonged
mitotic delay. We have found that the Gin4 protein can be
detected among the proteins that elute from a Cla4 affinity
column, consistent with a functional relationship between
Cla4 and Gin4 (data not shown). However, Gin4 is not
among the major proteins that are easily visualized by
Coomassie blue staining of the eluted fractions, and we
therefore suspect that the interaction between Cla4 and
Gin4 is either of low affinity or indirect.
Clb2 and the Cdc42 GTPase act synergistically to induce
hyperphosphorylation of Cla4
To learn more about the role of the Cla4 protein in
mitosis, we determined whether Cla4 undergoes mitosis-
specific regulation. As a first step, we arrested cells in
interphase or mitosis, and then used western blotting to
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Figure 2
Cla4 interacts genetically with proteins that
function in a Clb2-dependent mitotic control
pathway. (a) CLA4 interacts genetically with
NAP1 and GIN4. Strains carrying deletions of
the CLA4, GIN4 or NAP1 genes either alone
or in combination were grown on a YEPD
plate at 37°C. (b) CLA4 interacts genetically
with the mitotic cyclins. The indicated strains
were grown in liquid YEPD media to log
phase at 30°C and photographed using
Nomarski optics. (c) Deletion of the NAP1
gene suppresses the temperature sensitivity
of the cdc42-1 allele. The indicated strains
were grown on a YEPD plate at 37°C. WT
indicates wild type.
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determine whether Cla4 undergoes a cell-cycle-specific
electrophoretic mobility shift that would be indicative of
post-translational modifications. We found that a small
fraction of the Cla4 protein was shifted to slower-migrat-
ing forms in cells arrested in mitosis (Figure 4a). A similar
fraction of Cla4 was shifted during mitosis when a syn-
chronized population of cells went through a normal cell
cycle. If the Cla4 protein from mitotic cells was treated
with phosphatase these slower-migrating forms disap-
peared, demonstrating that Cla4 is hyperphosphorylated
(data not shown, but see Figure 4c below).
This result raises two questions. First, why does only a frac-
tion of Cla4 undergo hyperphosphorylation during mitosis?
Also, what factors are responsible for inducing the mitosis-
specific hyperphosphorylation of Cla4? To begin to answer
these questions, we looked more closely at the regulation
of Cla4 hyperphosphorylation. Cla4 is known to be acti-
vated in vitro by binding of the GTP-bound form of Cdc42
[8,16]. It therefore seemed possible that hyperphosphoryla-
tion of Cla4 is the result of autophosphorylation induced by
binding of the GTP-bound form of Cdc42 to Cla4. In addi-
tion, as Cla4 hyperphosphorylation is a mitosis-specific
event and Cla4 shows genetic interactions with Clb2, it also
seemed possible that the mitotic cyclin Clb2 may somehow
have a role in Cla4 hyperphosphorylation. We therefore
determined whether overexpression of Clb2 and/or the
GTP-bound form of Cdc42 causes the hyperphosphoryla-
tion of Cla4. For these experiments, we used the condi-
tional GAL10 promoter to express a mutant form of Cdc42
that is locked into the GTP-bound form (called Cdc42V12)
[17]. Similarly, we used the GAL1 promoter to express a
version of Clb2 that lacks the ‘destruction box’ that targets
Clb2 for destruction during interphase (called Clb2∆176),
thereby allowing Clb2 to accumulate in cells during inter-
phase [18]. Before inducing expression of Clb2∆176 or
Cdc42V12, we arrested cells in interphase so that we could
study the effects of these proteins under conditions where
there are no other mitotic cyclins present. We found that
expression of Clb2∆176 or Cdc42V12 alone did not induce a
major shift in the electrophoretic mobility of Cla4. Expres-
sion of the two proteins together, however, led to a rapid
and dramatic electrophoretic mobility shift (Figure 4b).
Treatment of Cla4 with phosphatase caused the elec-
trophoretic mobility shift to disappear, demonstrating that
it is due to hyperphosphorylation (Figure 4c).
The wild-type version of Cdc42 was not capable of induc-
ing Cla4 hyperphosphorylation, demonstrating that only the
GTP-bound form of Cdc42 is able to induce this event
(Figure 4b). Similarly, a non-degradable form of a related
mitotic cyclin called Clb3∆46 was only able to induce weak
hyperphosphorylation of Cla4, indicating that hyperphos-
phorylation is a Clb2-specific function rather than a result of
arresting cells in mitosis (Figure 4d). Controls demonstrated
that the non-degradable form of Clb3 was able to arrest cells
in mitosis with large buds in the same manner as Clb2 (data
not shown). The fact that only a fraction of Cla4 undergoes
hyperphosphorylation during a normal cell cycle suggests
either that hyperphosphorylation is a highly transient event,
or that only a fraction of Cla4 is used during mitosis.
In previous work, we found that overexpression of a non-
degradable form of Clb2 in cells arrested in interphase is
able to induce hyperphosphorylation of Gin4 (see
Figure 11 of Altman and Kellogg [7]). In those studies
however, we found that only a fraction of Gin4 is induced
to undergo hyperphosphorylation by expression of Clb2,
which we could detect on a long exposure of a western
blot. We suspect that a small fraction of Gin4 is hyper-
phosphorylated in this situation because a fraction of the
Cdc42 in the cell is transiently in the GTP-bound form.
We only observe rapid and quantitative hyperphosphory-
lation of Gin4 when both Clb2 and the GTP-bound form
of Cdc42 are expressed together.
The hyperphosphorylated form of Cla4 is likely to signal
the activation of the Gin4 kinase
We next addressed the effect of expression of 
Clb2∆176 and Cdc42V12 on Gin4 activation. As with Cla4
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Figure 3
Cla4 is required for the mitosis-specific hyperphosphorylation of the
Gin4 kinase. (a) Wild-type (WT) and ∆cla4 cells were synchronized in
G1 by arrest with the mating pheromone α-factor and were then
released from the arrest and allowed to progress through the cell
cycle. At each of the indicated times, samples were taken and the
hyperphosphorylation of Gin4 was assayed as previously described
using an anti-Gin4 antibody as a probe [7]. Hyperphosphorylation is
indicated by a shift in electrophoretic mobility of the Gin4 protein.
(b) A cell-cycle time course was carried out as in (a), except that the
samples were probed for the Clb2 mitotic cyclin with anti-Clb2
antibody. This experiment was carried out independently of the
experiment shown in (a), and the cells entered mitosis slightly later.
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hyperphosphorylation, we found that Gin4 became hyper-
phosphorylated only in the situation where Clb2∆176 and
Cdc42V12 were expressed together (Figure 5a). Further-
more, we found that expression of Clb2∆176 and Cdc42V12
together in a ∆cla4 strain did not lead to Gin4 hyperphos-
phorylation (Figure 5b), consistent with our previous
results demonstrating that the mitosis-specific activation
of Gin4 required Cla4 (see Figure 3a). These results
provide further evidence that Cla4 is required for activa-
tion of the Gin4 kinase, and they argue strongly that the
hyperphosphorylated form of Cla4 is responsible for sig-
naling the activation of Gin4.
Cdc42 is required for the mitosis-specific
hyperphosphorylation of Gin4
The previous results suggest that Cdc42 should be
required for the mitosis-specific hyperphosphorylation of
Gin4. To test whether this is true, cells carrying the cdc42-1
temperature sensitive mutation were arrested in mitosis by
treatment with the microtubule polymerization inhibitor
benomyl. We then shifted the cells to the restrictive tem-
perature for 2 hours in the continued presence of benomyl,
and used western blotting to assay Gin4 hyperphosphoryla-
tion. We found that Gin4 hyperphosphorylation was lost at
the restrictive temperature in the cdc42-1 cells, but not in
wild-type control cells, as expected if Cdc42 is required for
Gin4 hyperphosphorylation (Figure 5c).
Nap1 and Cdc28, but not Gin4, are required for Cla4
hyperphosphorylation
To further delineate the requirements for Cla4 hyper-
phosphorylation, we assayed the ability of Clb2∆176 and
Cdc42V12 to induce hyperphosphorylation of Cla4 in
various mutant backgrounds. We found that Cla4 
hyperphosphorylation did not occur at the restrictive tem-
perature in cells carrying a temperature-sensitive allele of
the CDC28 gene, consistent with the idea that Cla4 func-
tions in a pathway that is activated by the Clb2–Cdc28
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Figure 4
Hyperphosphorylation of Cla4 is induced by
Clb2 and the GTP-bound form of Cdc42.
(a) Cla4 is hyperphosphorylated in mitosis.
Cells were arrested in interphase with α-factor
or in mitosis with benomyl, and samples were
immunoblotted with affinity-purified anti-Cla4
antibodies. A sample from a ∆cla4 strain
served as a control for the specificity of the
anti-Cla4 antibodies. The arrow points to the
hyperphosphorylated form of Cla4 observed
in mitotic cells. (b) The combined activity of
Clb2∆176 and Cdc42V12 induces Cla4
hyperphosphorylation. Cells were induced to
express Clb2∆176, Cdc42V12, Cdc42V12 and
Clb2∆176, or wild-type Cdc42 and Clb2∆176
together. Samples were collected at 1 h
intervals after induction of expression and
were immunoblotted with anti-Cla4
antibodies. (c) Cla4 is hyperphosphorylated in
cells that express Clb2∆176 and Cdc42V12.
Cla4 was immunoprecipitated from cells
expressing both Cdc42V12 and Clb2∆176, and
the immunoprecipitated Cla4 was treated with
either a buffer control (–) or with
λ-phosphatase (PPase; +) followed by
immunoblotting with anti-Cla4 antibodies.
(d) The mitotic cyclin Clb3 is unable to induce
full hyperphosphorylation of Cla4. Cells
expressing Clb3∆46 and Cdc42V12 were
assayed for Cla4 hyperphosphorylation.
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Figure 5
Hyperphosphorylation of Cla4 is needed for the hyperphosphorylation
of Gin4. (a) Hyperphosphorylation of Gin4 correlates with Cla4
hyperphosphorylation. The same samples used to assay Cla4
hyperphosphorylation in Figure 4b were immunoblotted with anti-Gin4
antibodies to assay for Gin4 hyperphosphorylation. (b) Cla4 is
required for the Cdc42V12- and Clb2∆176-induced activation of Gin4.
Samples from a ∆cla4 strain that overexpresses both Cdc42V12 and
Clb2∆176 were immunoblotted with anti-Gin4 antibodies. (c) Cdc42 is
required for the mitosis-specific hyperphosphorylation of Gin4. Log-
phase wild-type and cdc42-1 cells were pretreated with 30 µg/ml
benomyl at 23°C for 1 h before incubation at 23°C or at 37°C for an
additional 2 h. Extracts made from the yeast cells were then
immunoblotted with anti-Gin4 antibodies.
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kinase complex (Figure 6a). We also found that Cla4
hyperphosphorylation occurs normally in ∆gin4 cells, con-
sistent with the idea that Cla4 functions to activate the
Gin4 kinase (Figure 6b). In contrast, Cla4 hyperphospho-
rylation is significantly reduced in ∆nap1 cells (Figure 6c),
consistent with the genetic interactions between Nap1
and Cla4 (see Figure 2a), and with other results demon-
strating an involvement of Nap1 in the pathway used by
Clb2 and Cdc28 to control bud growth during mitosis
[4,7]. As Nap1 is also required for the activation of the
Gin4 kinase and we have detected a tight biochemical
interaction between Gin4 and Nap1, it appears that Nap1
may have an integral role in the regulation of both Cla4
and Gin4 kinases [7].
The in vitro kinase activity of Cla4 is not regulated by
hyperphosphorylation
In previous work, it was found that Cla4 kinase activity
can be detected throughout the cell cycle, and that kinase
activity increases approximately sevenfold during mitosis
[16]. We therefore tested whether hyperphosphorylation
of Cla4 leads to changes in Cla4 kinase activity. To do
this, we immunoprecipitated Cla4 from log-phase cells
and from cells expressing Clb2∆176 and Cdc42V12, and then
assayed kinase activity using myelin basic protein as a sub-
strate. As controls we used strains carrying either a dele-
tion of the CLA4 gene or a mutant version of CLA4 in
which an essential lysine in the kinase active site is
changed to an alanine (Cla4K594A). We found that the in
vitro kinase activity of Cla4 is not significantly affected by
the hyperphosphorylation of Cla4 (Figure 7, compare
uninduced and induced lanes). This result does not rule
out the possibility that the kinase activity of Cla4 is regu-
lated by hyperphosphorylation in vivo.
Discussion
Cla4 and Cdc42 function in a Clb2-dependent mitotic
control pathway
A variety of biochemical and genetic experiments demon-
strate that Cla4 and Cdc42 function in a mitotic control
pathway that includes Clb2, Cdc28, Nap1 and Gin4. First,
deletion of the CLA4 gene causes an elongated bud phe-
notype that is nearly identical to the phenotype caused by
loss of function of Clb2, Nap1 or Gin4 in cells that are
dependent upon Clb2 for survival. Second, CLA4 interacts
genetically with GIN4, NAP1 and the mitotic cyclins, and
CDC42 interacts genetically with NAP1. Third, Cla4 is
required in vivo for the mitosis-specific hyperphosphoryla-
tion of Gin4. Fourth, Cla4 hyperphosphorylation is
induced in vivo by the combined activity of Clb2, Cdc28,
Nap1 and the GTP-bound form of Cdc42. Finally, strong
hyperphosphorylation of Cla4 can be induced by Clb2, but
not by the related mitotic cyclin Clb3, demonstrating that
Cla4 functions in a Clb2-specific pathway. Figure 8 sum-
marizes the epistasis relationships that we have observed
in this study. It should be stressed, however, that several
results are not consistent with a simple linear signaling
pathway. For example, cells carrying deletions of the
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Figure 6
Cdc28 and Nap1, but not Gin4, are required for Cla4
hyperphosphorylation. (a) Expression of Cdc42V12 and Clb2∆176 was
induced with galactose in wild-type (WT) and cdc28-4 cells at 37°C.
Samples were collected at 1 h intervals and assayed for Cla4
hyperphosphorylation. Note that Cla4 hyperphosphorylation does not
occur as efficiently at 37°C in the wild-type control cells as it does at
30°C (data not shown). (b) Expression of Cdc42V12 and Clb2∆176 was
induced in ∆gin4 cells. Samples were collected at 1 h intervals and
assayed for Cla4 hyperphosphorylation. (c) Expression of Cdc42V12
and Clb2∆176 was induced in ∆nap1 cells. Samples were collected at
1 h intervals and assayed for Cla4 hyperphosphorylation.
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Figure 7
The in vitro kinase activity of Cla4 is not regulated by
hyperphosphorylation. The Cla4 protein was immunoprecipitated from
rapidly growing wild-type yeast cells and assayed for kinase activity. As
controls for the specificity of the kinase assay, ∆cla4 cells or cells
carrying the cla4K594A kinase-dead mutation were used. To test
whether hyperphosphorylation of Cla4 leads to activation of kinase
activity, kinase assays were carried out either using cells in which Cla4
hyperphosphorylation was induced by expression of Cdc42V12 and
Clb2∆176, or using uninduced control cells.
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genes for both Cla4 and Gin4 have a more severe pheno-
type than either single deletion (see Figure 2), and Gin4
and Nap1 bind directly to each other. It seems likely that
signaling events in this pathway are carried out by multi-
protein complexes, and that there is cross-talk between
intricate and partially redundant pathways, as has been
observed for other signaling pathways [19–21].
Previous studies on Cla4 and a related member of the
PAK kinase family called Ste20 also provide strong evi-
dence supporting the idea that Cla4 functions during
mitosis. It was found that cells carrying a ste20 deletion
and a temperature-sensitive allele of cla4 arrest early in
mitosis with a short spindle when shifted to the restrictive
temperature, consistent with the idea that Cla4 carries out
mitotic functions [8]. The fact that the ∆ste20 cla4ts cells
arrest with a short spindle is also consistent with the idea
that Cla4 functions with Gin4 and Nap1, as loss of func-
tion of either of these genes can also cause a prolonged
delay at the short spindle stage [4,7]. Interestingly, Cla4
and Gin4 were both identified in screens for mutations
that cause lethality in combination with a double deletion
of the G1 cyclin genes CLN1 and CLN2 [8,16,22,23].
Although the basis for the synthetic lethality is unknown,
this finding supports the idea that Gin4 and Cla4 are
involved in related cell-cycle functions.
Several recent studies also support the idea that Cdc42
carries out mitotic functions. First, newly isolated mutant
alleles of the CDC42 gene cause the formation of elongated
buds, consistent with the idea that Cdc42 function is
required during mitosis to induce the switch from polar to
isotropic bud growth (K. Kozminski and D. Drubin, per-
sonal communication). The original cdc42-1 allele also pro-
duces a fraction of cells with elongated buds when crossed
into the W303 strain background [8]. Second, independent
genetic screens for regulators of Cdc42 and for suppressors
of a mutant cdc28 allele both led to the identification of
related proteins called Zds1 and Zds2. Cells carrying dele-
tions of the genes for both Zds1 and Zds2 grow very
slowly, have elongated buds, and undergo prolonged
delays in early mitosis at the short spindle stage [24,25].
Cla4 and Ste20 show a high degree of sequence similarity
and share redundant functions in vivo [8,26,27]. However,
we observed that Gin4 activation fails to occur in ∆cla4
cells that have a wild-type copy of the STE20 gene. In
addition, we have so far been unable to detect any genetic
interactions between STE20 and GIN4, NAP1 or CLB2
(data not shown). Therefore, it is unlikely that Cla4 and
Ste20 share redundant functions in the pathway or path-
ways used to control Gin4 activation and polar bud growth.
Cla4 undergoes mitosis-specific hyperphosphorylation
We found that a fraction of the total Cla4 protein present
in the cell becomes hyperphosphorylated during mitosis.
As Cla4 is known to interact with the Cdc42 GTPase, we
reasoned that only a fraction of Cla4 undergoes hyper-
phosphorylation during mitosis because hyperphosphory-
lation is a transient event that can only be induced by the
GTP-bound form of Cdc42. Consistent with this idea, we
found that coexpression of Clb2 and the GTP-bound form
of Cdc42 leads to nearly quantitative hyperphosphoryla-
tion of Cla4, even in cells arrested in interphase. Two
lines of evidence argue strongly that Cla4 hyperphospho-
rylation is a biologically relevant event with an important
role in the Clb2-dependent pathway that controls polar
bud growth during mitosis. First, Clb2, Cdc28 and Nap1
are all required in vivo for Cla4 hyperphosphorylation, and
each of these proteins has previously been shown to func-
tion in the Clb2-dependent pathway. Second, we have so
far found that Gin4 hyperphosphorylation only occurs
when Cla4 becomes hyperphosphorylated, suggesting that
the hyperphosphorylated form of Cla4 is responsible for
signaling the hyperphosphorylation of Gin4.
We do not yet understand how hyperphosphorylation reg-
ulates Cla4 activity. Hyperphosphorylation does not
appear to have any significant effect on Cla4 kinase activ-
ity in vitro, although this does not rule out the possibility
that hyperphosphorylation regulates kinase activity in
vivo. One possibility is that hyperphosphorylation regu-
lates the ability of Cla4 to bind to other proteins that func-
tion in the pathway. For example, perhaps Cla4
hyperphosphorylation causes assembly of a transient
complex that leads to activation of the Gin4 kinase.
The in vivo functions of the Cdc42 GTPase
Studies carried out in vitro have demonstrated that
members of the PAK kinase family are activated by
binding of the GTP-bound form of the Cdc42 GTPase,
but not the GDP-bound form, suggesting that Cdc42 may
function as an on/off switch for PAK kinases [9,28]. It is
interesting to note, however, that the GTP-bound form of
Cdc42 is necessary, but not sufficient, for the induction of
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Figure 8
A model summarizing the epistasis relationships observed in this study.
The Clb2–Cdc28 kinase complex induces the hyperphosphorylation of
the Cla4 kinase in a Nap1-dependent and Cdc42-dependent manner,
and the hyperphosphorylated form of Cla4 appears to signal the
activation of the Gin4 kinase. The activated form of Gin4 negatively
regulates polar bud growth and may play a part in the assembly or
function of the mitotic spindle (see Discussion).
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Cla4 hyperphosphorylation. This finding suggests that the
function of Cdc42 in vivo may be more complex than
simply acting as an on/off switch for the activation of
protein kinases. Cdc42 has been implicated in a remark-
ably wide variety of cellular events, and it remains unclear
how the same protein functions in so many different con-
texts [29,30]. Indeed, the exact molecular role of Cdc42 in
vivo remains unclear. One interesting possibility is that
Cdc42 functions to monitor the specificity of signaling
reactions by linking multiprotein complex formation
and/or phosphorylation events to GTP hydrolysis.
The role of Cla4 in the control of cell-cycle events
Cla4 is required in vivo for the mitosis-specific activation
of the Gin4 kinase, and for the proper control of bud
growth during mitosis. In addition, loss of Cla4 function in
∆ste20 cells causes an arrest at the short spindle stage. It is
unclear at present why loss of function of Cla4, Gin4 or
Nap1 can cause prolonged mitotic delays at the short
spindle stage, although there are a number of interesting
possibilities. One possible explanation is that these pro-
teins are directly involved in aspects of mitotic spindle
assembly, and loss of function causes cells to have diffi-
culty assembling a functional mitotic spindle. Another
possibility is that these proteins are primarily involved in
a pathway that controls bud growth during mitosis, and
defects in this pathway activate a checkpoint that arrests
the nuclear cycle at the short spindle stage. A third possi-
bility is that Cla4, Gin4 and Nap1 are part of a checkpoint
pathway that normally functions during mitosis to inacti-
vate a negative regulator of the cell cycle when mitotic
events are occurring properly. Loss of function of such a
pathway would result in a failure to inactivate the
inhibitor, which would lead to a mitotic delay. A final pos-
sibility is that Cla4, Nap1 and Gin4 function in a pathway
that triggers the destruction of mitotic cyclins or other
proteins that must be destroyed before cells can exit
mitosis. These various possibilities are not mutually
exclusive. For example, studies on the DNA damage
checkpoint have demonstrated that proteins involved in
carrying out specific cell-cycle events can also be involved
in checkpoints that detect when cell-cycle events have
not occurred properly [31,32].
Control of cell-cycle events by cyclin-dependent kinases
The mechanisms used by cyclin-dependent kinases to
induce and coordinate the events of the cell cycle are
largely unknown. For example, it remains unclear
whether cyclin-dependent kinases directly phosphorylate
proteins involved in cell-cycle events, or whether they
activate intricate signaling pathways that ultimately regu-
late the proteins directly involved in cell-cycle events.
Given the complexity of cell-cycle events and the fact
that they must be precisely controlled, it would not be
unexpected to find that they are regulated by intricate
signaling pathways.
We have found that Cla4 and Cdc42 have critical roles in a
pathway used by the Clb2–Cdc28 cyclin-dependent
kinase complex to control certain mitotic events. We also
found that Nap1, the Clb2–Cdc28 kinase complex and the
GTP-bound form of Cdc42 work together to induce
hyperphosphorylation of Cla4, and that Cla4 is required
for the mitosis-specific activation of the Gin4 kinase.
These results show that the Clb2–Cdc28 kinase complex
controls specific events of mitosis through a GTPase-
linked signaling mechanism. It seems possible that cyclin-
dependent kinases may control many other cell-cycle
events by activating complex signaling cascades rather
than by directly phosphorylating proteins involved in spe-
cific events. Additional genetic and biochemical studies
should lead to the identification of more proteins that
function in the Clb2-dependent mitotic control pathway,
as well as to an understanding of the molecular mecha-
nisms underlying the mitosis-specific regulation of the
Cla4 and Gin4 kinases.
Materials and methods
Strains used in this study
All strains are in the W303 background (leu2-3,112 ura3-52 can1-
100 ade2-1 his3-11 trp1-1 ssd1 ho). DK278 was derived by crossing
the cdc42-1 mutant allele into the W303 background three times.
DK96: Matα ∆nap1::LEU2. DK186: Mata ∆bar1. DK212: Mata ∆clb1
∆clb3::TRP1 ∆clb4::HIS3 ∆bar1. DK247: Mata URA3::gal-
CLB2∆176∆bar1. DK278: Mata cdc42-1. DK281: Mata CLA4K594A
∆bar1. RA4: Mata ∆gin4::LEU2. JC2: Mata ecm30-2 ∆clb3::TRP1
∆clb4::HIS3. HT1: Mata ∆cla4::URA3 ∆bar1. HT9: Mata
∆cla4::URA3 ∆clb1 ∆clb3::TRP1 ∆clb4::HIS3 ∆bar1. HT15: Mata
∆gin4::LEU2 ∆cla4::URA3. HT16: Mata ∆nap1::LEU2 ∆cla4::URA3.
HT31: Mata URA3::gal1-CLB2∆176/gal10-CDC42V12 ∆bar1. HT36:
Mata cdc28-4 URA3::gal1-CLB2∆176/gal10-CDC42V12. HT37: Mata
URA3::gal10-CDC42V12 ∆bar1. HT39: Mata URA3::gal1-
CLB2∆176/gal10-CDC42 ∆bar1. HT42: Mata URA3::gal1-
CLB3∆46/gal10-CDC42V12 ∆bar1. HT46: Mata ∆cla4::LEU2
URA3::gal1-CLB2∆176/gal10-CDC42V12 ∆bar1. HT52: Mata
∆gin4::LEU2 cdc42-1. HT53: Mata ∆nap1::LEU2 cdc42-1. HT54:
Mata ∆gin4::LEU2 URA3::gal1-CLB2∆176 /gal10-CDC42V12. HT55:
Mata ∆nap1::LEU2 URA3::gal1-CLB2∆176 /gal10-CDC42V12.
Cloning and deletion of the CLA4 gene
We cloned the CLA4 gene by complementation using a genomic library
carried in a CEN plasmid. The cloning was aided by the fact that the
original mutant allele identified in our genetic screen is hypersensitive to
hydroxyurea. After transforming mutant cells with the plasmid library, we
were therefore able to grow cells on plates containing 5 mg/ml hydrox-
yurea, which strongly inhibited the growth of mutant cells without signif-
icantly affecting the growth of wild-type cells. Cells carrying the NAP1
deletion are also hydroxyurea sensitive (D. Kellogg, unpublished obser-
vations). The original mutation segregates 2:2 with a deletion of the
CLA4 gene, demonstrating that the mutation lies in the CLA4 gene.
To delete the CLA4 gene, we used PCR to amplify the URA gene from
the pRS306 vector with 60 bases of homology to the 5′ and 3′ ends of
the CLA4 open reading frame on each end (primers: ATGTCTCTTTC-
AGCTGCAGCGAATAAGATATCTGACAACGATTTCCAAAATATCG
GACCGGCCGGCATCAGAGCAGATTGTAC and TCATTCCTT-
CCACTCCAACAGTGATGTCAAATCCTTTGGATCACATGCCATATT
GAAAAAACCGTCCTTACGCATCTGTGCGGTAT). The resulting
PCR product was transformed into strain DK186 or DK212, and cells
carrying the CLA4 deletion were identified by PCR and confirmed by
western blotting.
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Overexpression of Clb2∆176 and Cdc42V12
To create plasmids that express Clb2∆176 and Cdc42V12 we used the
plasmid pDK20, which carries the bidirectional GAL1/10 promoter
cloned into the KpnI and XhoI sites of pRS306. A plasmid that
expresses Cdc42V12 under the control of the GAL10 promoter was
constructed by cloning the DNA encoding Cdc42V12 into the GAL10
side of the promoter (pHT26), and a plasmid that expresses Clb2∆176
under the control of the GAL1 promoter was constructed by cloning
the DNA encoding Clb2∆176 into the GAL1 side of the promoter
(pAR39-1, gift of Adam Rudner). To construct a plasmid that expresses
both proteins, Clb2∆176 and Cdc42V12 were cloned into pDK20
together into the same sites described above. Plasmids that express
wild-type Cdc42 and Clb2∆176, or Cdc42V12 and Clb3 were con-
structed in the same manner (pHT28 and pDK59, respectively). All
plasmids were integrated at the URA3 gene.
To induce expression of proteins, yeast cells were grown overnight at
room temperature to an OD600 of 0.5–0.6 in YEP media containing 2%
glycerol and 2% ethanol. The cells were arrested in interphase by addi-
tion of α-factor to 2 µg/ml, followed by incubation at 30°C for 2 h.
Expression of proteins was then induced by the addition of galactose
to 2%, and 1.6 ml samples are taken at the indicated times. Samples
were prepared for electrophoresis and western blotting as previously
described [7].
Cell-cycle arrests and detection of proteins
Cell-cycle arrests and preparation of samples for gel electrophoresis
and western blotting were carried out as previously described [7]. To
resolve differently phosphorylated forms of Cla4, we electrophoresed
samples through 10% polyacrylamide gels (6.5 by 14.0 cm) for 3 h at
185 V [33]. To detect Cla4, we used an affinity-purified rabbit poly-
clonal antibody raised against a glutathione-S-transferase (GST) fusion
protein that includes amino acids 140–511 of the Cla4 protein. Gin4
hyperphosphorylation was assayed as previously described [7]. For the
experiment shown in Figure 5c, cells carrying the cdc42-1 allele were
incubated in the presence of 30 µg/ml benomyl in YPD media at room
temperature for 1 h before shifting to the restrictive temperature of
37°C for 2 h.
Treatment of Cla4 with phosphatase
Cla4 was immunoprecipitated from cells expressing Clb2∆176 and
Cdc42V12 and treated with lambda phosphatase (New England
Biolabs) as previously described for Gin4 [7].
Construction of a Cla4 kinase domain mutant and Cla4
kinase assays
To generate a catalytically inactive mutant version of Cla4, two PCR
reactions were carried out to amplify the 5′ and 3′ ends of the open
reading frame, overlapping by 20 base pairs. The first oligo pair was
GCGGAATTCGTATCATCAGACAGTAACTCC (Cla4-33) and
GATAGCAACTTTATCTCCTA (Cla4-38), while the second pair was
GAGATAAAGTTGCTATCGCGCAAATGGTCTTATCTAAAC (Cla4-
35) and GCGCAAGCTTTCATTCCTTCCACTCCAACAG (Cla4-37).
The Cla4-35 oligo incorporates two mismatched bases that change the
conserved lysine in subdomain II to an alanine. The products of these
two reactions were gel purified, mixed together, and used as a tem-
plate for a PCR reaction with primers Cla4-33 and Cla4-37 to generate
a full-length fragment that incorporates the mutation, which was cloned
into the vector YIplac211. The resulting vector (pDM2) was digested
with AvrII to target integration at the CLA4 gene, and transformants
were grown in the presence of 5-fluoro-orotic acid to select for recom-
bination events between the duplicated CLA4 sequences that loop out
the URA3 gene. Recombination events that leave the mutation in the
genomic copy of Cla4 were identified by PCR. This procedure was
carried out with two different plasmid isolates, both of which gave the
same results.
To assay Cla4 kinase activity, the cells from 15 ml of culture at an
OD600 of 0.7 were harvested and frozen on liquid nitrogen. Cla4 was
then immunoprecipitated and assayed as previously described for Gin4
kinase assays, except that 2.5 µg myelin basic protein was used as a
substrate for each assay [7].
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